Shares outstanding increased 100.2%
Shares outstanding changed +100.2% from the comparable as-filed period. The change ranks at the 100th percentile of 5 prior comparable changes.
24,425,762→48,890,1215 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ARTV financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy increased 13.6%
Free-cash-flow proxy changed +13.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$24.0M→-$20.8M3 prior comparisons
Operating income decreased 17.9%
Operating income changed -17.9% from the comparable as-filed period.
-$22.8M→-$26.9M2 prior comparisons
Operating cash flow increased 11.4%
Operating cash flow changed +11.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$23.0M→-$20.4M3 prior comparisons
Working capital increased 144.2%
Working capital changed +144.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$138.3M→$337.7M3 prior comparisons
Working capital / assets moved 996 bp higher
Working capital / assets changed +996 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
81.64%→91.61%3 prior comparisons
Current assets increased 136.3%
Current assets changed +136.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$149.1M→$352.3M3 prior comparisons
Current ratio increased 74.5%
Current ratio changed +74.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
13.84→24.163 prior comparisons
Total assets increased 117.6%
Total assets changed +117.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$169.4M→$368.6M3 prior comparisons
Research & development increased 22.8%
Research & development changed +22.8% from the comparable as-filed period.
$17.9M→$21.9M2 prior comparisons
Capital expenditure decreased 60.7%
Capital expenditure changed -60.7% from the comparable as-filed period.
$1.1M→$415,0003 prior comparisons
Current liabilities increased 35.4%
Current liabilities changed +35.4% from the comparable as-filed period.
$10.8M→$14.6M3 prior comparisons
Stock-based compensation increased 20.4%
Stock-based compensation changed +20.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.5M→$1.9M2 prior comparisons
Cash & equivalents changed across a low base
Cash & equivalents changed +958.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base. This reverses 2 consecutive comparable moves in the opposite direction.
$28.5M→$301.5M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.